Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1)

Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease




Julkaisun tekijätWaggan Imran, Rissanen Eero, Tuisku Jouni, Joutsa Juho, Helin Semi, Parkkola Riitta, Rinne Juha O, Airas Laura

KustantajaSPRINGER HEIDELBERG

Julkaisuvuosi2023

JournalJournal of Neurology

Tietokannassa oleva lehden nimiJOURNAL OF NEUROLOGY

Lehden akronyymiJ NEUROL

Volyymi270

Aloitussivu300

Lopetussivun numero310

Sivujen määrä11

ISSN0340-5354

DOIhttp://dx.doi.org/10.1007/s00415-022-11342-1

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/177923535


Tiivistelmä
Introduction Adenosine 2A (A(2A)) receptors co-localize with dopamine D-2 receptors in striatopallidal medium spiny neurons of the indirect pathway. A(2A) receptor activation in the striatum or pallidum decreases D-2 signaling. In contrast, A(2A) receptor antagonism may help potentiate it. Furthermore, previous PET studies have shown increased A(2A) receptor availability in striatum of late-stage PD patients with dyskinesia. However, human in vivo evidence for striatal A(2A) receptor availability in early-stage PD is limited. This study aimed to investigate possible differences in A(2A) receptor availability in the striatum and pallidum of early- and moderate-stage PD patients without dyskinesias. Methods Brain MRI and PET with [C-11]TMSX radioligand, targeting A(2A) receptors, was performed in 9 patients with early- and 9 with moderate-stage PD without dyskinesia and in 6 healthy controls. Distribution volume ratios (DVR) were calculated to assess specific [C-11]TMSX binding in caudate, putamen and pallidum. Results A(2A) receptor availability (DVR) was decreased in the bilateral caudate of early-stage PD patients when compared with healthy controls (P = 0.02). Conversely, DVR was increased bilaterally in the pallidum of moderate-stage PD patients compared to healthy controls (P = 0.03). Increased mean striatal DVR correlated with higher motor symptom severity (rho\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$rho$$\end{document} = 0.47, P = 0.02). Conclusion Our results imply regional and disease stage-dependent changes in A(2A) receptor signaling in PD pathophysiology and in response to dopaminergic medication.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Last updated on 2023-18-01 at 15:01